Humacyte Announces FDA Approval of SYMVESS™ (acellular tissue engineered vessel ...

Humacyte's SYMVESS, a bioengineered vascular conduit, received FDA full approval for extremity arterial injury repair, offering high patency and low amputation/infection rates, with a trained sales team ready for commercial launch.